Literature DB >> 18971118

Nutrition, metabolic factors and cancer risk.

Laure Dossus1, Rudolf Kaaks.   

Abstract

Excess body weight (adiposity) and physical inactivity are increasingly being recognized as major nutritional risk factors for cancer, and especially for many of those cancer types that have increased incidence rates in affluent, industrialized parts of the world. In this review, an overview is presented of some key biological mechanisms that may provide important metabolic links between nutrition, physical activity and cancer, including insulin resistance and reduced glucose tolerance, increased activation of the growth hormone/IGF-I axis, alterations in sex-steroid synthesis and/or bioavailability, and low-grade chronic inflammation through the effects of adipokines and cytokines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18971118     DOI: 10.1016/j.beem.2008.08.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  24 in total

Review 1.  A review on the role of L-carnitine in the management of tamoxifen side effects in treated women with breast cancer.

Authors:  Nahla E El-Ashmawy; Rania M Khalil
Journal:  Tumour Biol       Date:  2013-12-12

2.  Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma.

Authors:  Ji Soo Choi; Eun-Kyung Kim; Hee Jung Moon; Jin Young Kwak
Journal:  Endocrine       Date:  2014-05-25       Impact factor: 3.633

3.  A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer.

Authors:  Geoffrey C Kabat; Mimi Kim; Rowan T Chlebowski; Janu Khandekar; Marcia G Ko; Anne McTiernan; Marian L Neuhouser; Donna R Parker; James M Shikany; Marcia L Stefanick; Cynthia A Thomson; Thomas E Rohan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

4.  Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts.

Authors:  Tanja Stocks; Kilian Rapp; Tone Bjørge; Jonas Manjer; Hanno Ulmer; Randi Selmer; Annekatrin Lukanova; Dorthe Johansen; Hans Concin; Steinar Tretli; Göran Hallmans; Håkan Jonsson; Pär Stattin
Journal:  PLoS Med       Date:  2009-12-22       Impact factor: 11.069

Review 5.  Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases.

Authors:  Sandeep Rana; Elizabeth C Blowers; Amarnath Natarajan
Journal:  J Med Chem       Date:  2014-08-28       Impact factor: 7.446

6.  A survey of etiologic hypotheses among testicular cancer researchers.

Authors:  A Stang; B Trabert; C Rusner; C Poole; K Almstrup; E Rajpert-De Meyts; K A McGlynn
Journal:  Andrology       Date:  2014-12-23       Impact factor: 3.842

7.  Dash of faith: a faith-based participatory research pilot study.

Authors:  Brook E Harmon; Swann A Adams; Dolores Scott; Yvonne S Gladman; Bernice Ezell; James R Hebert
Journal:  J Relig Health       Date:  2014-06

8.  O-GlcNAcylation stabilizes β-catenin through direct competition with phosphorylation at threonine 41.

Authors:  Stéphanie Olivier-Van Stichelen; Vanessa Dehennaut; Armelle Buzy; Jean-Luc Zachayus; Céline Guinez; Anne-Marie Mir; Ikram El Yazidi-Belkoura; Marie-Christine Copin; Didier Boureme; Denis Loyaux; Pascual Ferrara; Tony Lefebvre
Journal:  FASEB J       Date:  2014-04-17       Impact factor: 5.191

Review 9.  Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products.

Authors:  Manjinder Kaur; Chapla Agarwal; Rajesh Agarwal
Journal:  J Nutr       Date:  2009-07-29       Impact factor: 4.798

Review 10.  Influence of metabolic syndrome on upper gastrointestinal disease.

Authors:  Masahiro Sogabe; Toshiya Okahisa; Tetsuo Kimura; Koichi Okamoto; Hiroshi Miyamoto; Naoki Muguruma; Tetsuji Takayama
Journal:  Clin J Gastroenterol       Date:  2016-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.